Deletion or blocking CD146 steers ATMs toward anti‐inflammatory polarization, thus attenuating obesity‐induced chronic inflammation and metabolic dysfunction. The gene discussed is MCAM; the disease is obesity due to melanocortin 4 receptor deficiency.